Pay in 4 interest-free payments of $6.85 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
(R-KS) sent a bipartisan letter to the FDA flagging Hims & Hers' ad and accusing the company of misleading patients "by omitting any safety or side effect information when promoting a specific type of weight loss medication." Under federal law and regulations, FDA requires that prescription drug advertisements be truthful, not misleading, and balancedfailure to do so risks FDA enforcement action, including civil monetary penalties, Durbin and Marshall said in the letter
Injectable are offered by some clinics but have mixed results and varying safety profiles
Some of them also have additional indications reflecting their demonstrated benefits for cardiovascular disease, kidney health, and obesity
Gillian Goddard, MD, a board-certified endocrinologist with Park Avenue Endocrinology and Nutrition, spoke with MNT about the study findings
